LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients

NCT06795503 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer

NCT06508216 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer

NCT01698918 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer

NCT01525589 ·Status: COMPLETED ·Phase: PHASE2

Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In

NCT02708680 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein

NCT01918254 ·Status: COMPLETED ·Phase: PHASE1

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole

NCT05286437 ·Status: RECRUITING ·Phase: PHASE2

Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients

NCT03281824 ·Status: COMPLETED ·Phase: PHASE1

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC

NCT03184558 ·Status: TERMINATED ·Phase: PHASE2

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

NCT03099174 ·Status: COMPLETED ·Phase: PHASE1

BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer

NCT00708214 ·Status: COMPLETED ·Phase: PHASE2

Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer

NCT01623349 ·Status: COMPLETED ·Phase: PHASE1

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

NCT06797635 ·Status: RECRUITING ·Phase: PHASE2

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

NCT06570031 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor

NCT02444390 ·Status: COMPLETED ·Phase: NA

An Exploratory Clinical Study of Dalpiciclib an&Amp;#39;d Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast Cancer

NCT06605690 ·Status: NOT_YET_RECRUITING ·Phase: NA

Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer

NCT03078751 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

NCT02057133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

NCT00034125 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer

NCT04191382 ·Status: TERMINATED ·Phase: PHASE2

Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer

NCT03243838 ·Status: COMPLETED ·Phase: PHASE2

Study of E7389 for Advanced or Metastatic Breast Cancer

NCT00965523 ·Status: COMPLETED ·Phase: PHASE2

Real-world Data in Patients With Breast Cancer Treated With Abemaciclib

NCT04985058 ·Status: RECRUITING